Literature DB >> 14304400

[EXPERIMENTS ON VIRAL EXCRETION AND SERUM DIFFERENTIATION DURING A POLIOMYELITIS EPIDEMIC FOLLOWING ORAL VACCINATION WITH POLIOVIRUS TYPE-3].

R DEIBEL, W HORSTMANN.   

Abstract

Entities:  

Keywords:  GERMANY, WEST; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL; VIRUS CULTIVATION

Mesh:

Substances:

Year:  1965        PMID: 14304400     DOI: 10.1007/bf01485122

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  12 in total

1.  Antigenic variations among type 3 polioviruses.

Authors:  G R DUBES; I ARCHETTI; H A WENNER
Journal:  Am J Hyg       Date:  1959-07

2.  ANTIGENIC VARIATIONS AMONG TYPE III POLIOMYELITIS VIRUSES.

Authors:  R DEIBEL; D MACDONALD
Journal:  N Y State J Med       Date:  1964-08-15

3.  Serodifferentiation of poliovirus strains for studies of oral vaccine.

Authors:  H M GELFAND; J H NAKANO; J T COLE
Journal:  Public Health Rep       Date:  1962-11       Impact factor: 2.792

4.  The Coxsackie viruses.

Authors:  H PLAGER
Journal:  Ann N Y Acad Sci       Date:  1962-11-30       Impact factor: 5.691

5.  Antigenic characterization of oral poliovaccine progeny by neutralization kinetics.

Authors:  Y OZAKI; A R DIWAN; W D McBRIDE; J L MELNICK
Journal:  J Immunol       Date:  1963-02       Impact factor: 5.422

6.  The ECHO viruses.

Authors:  H A WENNER
Journal:  Ann N Y Acad Sci       Date:  1962-11-30       Impact factor: 5.691

7.  Antigenic analysis of polioviruses by kinetic studies of serum neutralization.

Authors:  W D McBRIDE
Journal:  Virology       Date:  1959-01       Impact factor: 3.616

8.  [On the history of the poliomyelitis vaccination with live viruses].

Authors:  H KOPROWSKI
Journal:  Schweiz Med Wochenschr       Date:  1959-12-19

9.  [Poliomyelitis vaccination with living attenuated viruses].

Authors:  W KELLER; O VIVELL
Journal:  Dtsch Med Wochenschr       Date:  1959-11-06       Impact factor: 0.628

10.  Poliomyelitis as a complex infection.

Authors:  G DALLDORF; H WEIGAND
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.